Maastricht University Medical Centre
Maastricht, Netherlands
NCT Number: NCT01588808
In the present study, the effects of 5 days of lower limb immobilization with or without twice-daily protein supplementation on muscle mass and muscle fiber characteristics will be determined. A young group will be included to compare the changes in muscle mass and muscle fiber characteristics between young and old men.
Looking for future studies?
Notify Me18 year–75 year
Male
Interventional
Not applicable
Maastricht, Netherlands
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Immobilization with protein (elderlY), immobilization without protein (elderly and young)
Time frame: three days before immobilization, and directly after immobilization (day of cast removal; day 6)
Time frame: three days before immobilization, and directly after immobilization (day of cast removal; day 6)
Time frame: Three days before immobilization, and directly after immobilization (day of cast removal; day 6)
Maastricht University Medical Center
Other
The Impact of Dietary Protein Supplementation and Age on Muscle Mass Loss During Short Term One-legged Knee Immobilization
Acronym: IM-PRO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06205784
Atrophy, Disuse Atrophy
Copenhagen, Capital Region, Denmark
View Trial DetailsNCT06228742
Atrophy, Atrophy, Disuse
Natick, Massachusetts, United States
View Trial DetailsNCT03454347
Disuse Atrophy, Muscular Diseases
Brookings, South Dakota, United States
View Trial DetailsNCT04422665
Atrophy, Disuse Atrophy
Edgbaston, West Midlands, United Kingdom
View Trial Details